Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2009-11-06
2011-11-01
Bradley, Christina (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S633000, C514S866000
Reexamination Certificate
active
08048873
ABSTRACT:
The invention refers to a synergistic pharmaceutical combination which comprises (a) a first pharmaceutical composition containing an antidiabetic or anti-hyperlipidemic active agent and one or more conventional carrier(s), and (b) a second pharmaceutical composition containing a hydroximic acid derivative of the formula I and one or more conventional carrier(s). The pharmaceutical combination is suitable for the prevention or treatment of, among others, diabetes mellitus.
REFERENCES:
patent: 4308399 (1981-12-01), Takacs et al.
patent: 5190970 (1993-03-01), Pan et al.
patent: 5328906 (1994-07-01), Nagy et al.
patent: 6011049 (2000-01-01), Whitcomb
patent: 6121278 (2000-09-01), Jackson et al.
patent: 6153632 (2000-11-01), Rieveley
patent: 6291495 (2001-09-01), Rieveley
patent: WO-0007580 (2000-02-01), None
patent: WO-0014054 (2000-03-01), None
American Diabetes Association, “Management of dyslipidemia in adults with diabetes”, Diabetes Care, 2003, vol. 26, pp. 83-S86.
Mayo Clinic (http://www.mayoclinic.org/metabolic-disorders/treatment.html), 2008.
Mayo Clinic (http://www.mayoclinic.com/print/hair-loss/DS00278), 2006.
Klein, et al., “Serum cholesterol in Wisconsin epidemiologic study of diabetic retinopathy,” Diabetes Care, 1992, vol. 15, pp. 282-287.
USPTO Office Action, U.S. Appl. No. 10/495,240, Nov. 1, 2006, pp. 1-7.
USPTO Office Action, U.S. Appl. No. 10/495,240, Feb. 28, 2007, pp. 1-15.
USPTO Office Action, U.S. Appl. No. 10/495,240, Feb. 1, 2008, pp. 1-13.
USPTO Office Action, U.S. Appl. No. 10/495,240, Oct. 30, 2008, pp. 1-11.
Literáti Nagy Péter
Rabloczky György
Rabloczky, legal representative András
Szilvássy Zoltán
Birch & Stewart Kolasch & Birch, LLP
Bradley Christina
N-Gene Research Laboratories Inc.
LandOfFree
Synergistic pharmaceutical combination for the prevention or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synergistic pharmaceutical combination for the prevention or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synergistic pharmaceutical combination for the prevention or... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4279411